US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its ...

US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the company, through subsidiary ...

In a further step in South Korea-based Celltrion’s ambitions to diversify from its core biosimilars focus, the company has ...

US pharma giant Pfizer (NYSE: PFE) reported financial results for the third quarter of 2025 on Tuesday. Revenues for the ...

Swiss specialty drugmaker Santhera Pharmaceuticals saw its shares rise 5.8% to 10.90 francs today, after it reported positive ...

George Tidmarsh has resigned as director of the US Food and Drug Administration’s Center for Drug Evaluation and Research ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

The US Food and Drug Administration (FDA) has approved Belgium drugmaker UCB’s Kygevvi (doxecitine and doxribtimine) powder ...

Tuesday is shaping up to be another dark day in the stock market for US genetic medicines company Sarepta Therapeutics as key ...

The bidding war for US obesity focused biotech Metsera, which has attracted offers from Pfizer and Novo Nordisk , and ...

SOTIO Biotech, a Czech clinical-stage biopharma owned by PPF Group, today announced the promotion of Dr Vivi Boura, an ...

Sickle cell disease (SCD) is a group of inherited blood disorders characterised by a single point mutation in the β-globin ...